Clinical Trial: Cannabidiol in Children With Refractory Epileptic Encephalopathy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Cannabidiol in Children With Refractory Epileptic Encephalopathy: A Phase 1 Open Label Dose Escalation Study (CARE-E)

Brief Summary: This study will assess the safety and tolerability of a cannabidiol-enriched Cannabis Herbal Extract in a small group of children with refractory epileptic encephalopathy. The dosage of Cannabis Herbal Extract will be gradually increased over a four month time period.